Recorded July 15, 2021
Continuing Education Hours: IAFNS is a Continuing Professional Education (CPE) provider with the Commission on Dietetic Registration (CDR). CDR Credentialed Practitioners will receive 1.0 Continuing Professional Education Unit (CPEU) for completion of this recorded webinar until July 15, 2024.
Description: Low- and no-calorie sweeteners (LNCSs) are a key tool for reduction of added sugars intake – which can be critical for individuals that have a health condition (e.g., diabetes) requiring attention to dietary carbohydrate. As part of the approval process for a new food ingredient, regulatory agencies set an Acceptable Daily Intake (ADI). Interpretation of LCS intakes in nutrition studies using the ADI affects the perception of LCS as a beneficial tool. In alignment with this perception, consumers, nutrition practitioners, and clinicians make decisions about using or advising use of LNCSs. There has been a rise in the number of publications that evaluate the safety of LNCSs for consumption which reference the ADI. Misinterpretation of the ADI can erode confidence in the safety and efficacy of LNCSs as a dietary tool, negatively impacting health management, despite that regulatory approvals already account for the ADI. There is an opportunity for explicitly detailing the derivation and appropriate application of the ADI to the nutrition community. This webinar will help researchers and clinicians to better understand what is meant by an ADI and to address patient and consumer concerns about LNCSs and their value as dietary management tools.
Welcome from IAFNS
The "ADI" for Low- and No-Calorie Sweeteners: Origin, Interpretation, and Application
- Dr. Daniele Wikoff, PhD, ToxStrategies
The LNCS ADI: Understanding Limits in Practice
- Dr. Deepa Handu, PhD RDN, The Academy of Nutrition and Dietetics
Q & A
Upon completion of this webinar, participants will be able to:
- Describe derivation of an acceptable daily intake (ADI) value and understand the underlying rationale and degree of protection conferred to consumers.
- Critically review and interpret nutrition research studies that apply the ADI as a health-based benchmark.
- Discuss science-based information on sweetener safety to patients and clients about the safety of LNCSs whether considered “natural”, “artificial”, or other.
- 4.1.2 Interprets and integrates evidence-based research and literature in decision making.
- 4.2.6 Analyzes and synthesizes information and identifies new information, patterns and findings.
- 6.2.3 Interprets data to make recommendations and to inform decisions
- 8.1.2 Applies knowledge of food and nutrition as well as the biological, physical and social science in practice